Clinical
You aim to evaluate the impact of molecules, medicines or treatment strategies on cognitive function during your trials ?
The services we offer
![clinique1 clinique1](http://www.cancerandcognition.com/wp-content/uploads/2015/04/clinique1.jpg)
Evaluation of cognitive impairment
in patients during clinical trials, with the possibility of conducting studies specifically adapted to elderly subjects
![clinique2 clinique2](http://www.cancerandcognition.com/wp-content/uploads/2015/04/clinique2.jpg)
Design and implementation of clinical studies
that focus on cognitive impairment with different types of treatments
![clinique3 clinique3](http://www.cancerandcognition.com/wp-content/uploads/2015/04/clinique3.jpg)
Examination of problems
related to aging or oral treatments
![clinique4 clinique4](http://www.cancerandcognition.com/wp-content/uploads/2015/04/clinique4.jpg)
Brain Imaging
(MRI, PET Scan)
“Our expertise concerns the assessment of cognitive impairment, especially with new targeted therapy, implementation of strategies for preventing and improving cognitive impairment, and monitoring cognitive function with oral therapy. Within the CNO, longitudinal, multicenter studies employ the teams from the anti-cancer centers as well as from psycho-oncology and oncogeriatric departments of Caen, Rouen and Lille.”